PT Merck Tbk Statistics

Total Valuation

PT Merck Tbk has a market cap or net worth of IDR 1.60 trillion. The enterprise value is 1.55 trillion.

Market Cap	1.60T
Enterprise Value	1.55T

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

PT Merck Tbk has 448.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	448.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	59.81M

Valuation Ratios

The trailing PE ratio is 12.91.

PE Ratio	12.91
Forward PE	n/a
PS Ratio	1.72
PB Ratio	2.20
P/TBV Ratio	2.20
P/FCF Ratio	22.77
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.53, with an EV/FCF ratio of 21.95.

EV / Earnings	12.44
EV / Sales	1.65
EV / EBITDA	9.53
EV / EBIT	12.19
EV / FCF	21.95

Financial Position

The company has a current ratio of 4.53, with a Debt / Equity ratio of 0.03.

Current Ratio	4.53
Quick Ratio	1.59
Debt / Equity	0.03
Debt / EBITDA	0.11
Debt / FCF	0.26
Interest Coverage	30.92

Financial Efficiency

Return on equity (ROE) is 16.95% and return on invested capital (ROIC) is 10.51%.

Return on Equity (ROE)	16.95%
Return on Assets (ROA)	8.59%
Return on Capital (ROIC)	10.51%
Revenue Per Employee	2.49B
Profits Per Employee	330.48M
Employee Count	372
Asset Turnover	1.01
Inventory Turnover	1.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.17% in the last 52 weeks. The beta is 0.56, so PT Merck Tbk's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	-15.17%
50-Day Moving Average	3,576.80
200-Day Moving Average	3,831.40
Relative Strength Index (RSI)	58.48
Average Volume (20 Days)	11,745

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Merck Tbk had revenue of IDR 934.62 billion and earned 124.26 billion in profits. Earnings per share was 277.37.

Revenue	934.62B
Gross Profit	326.15B
Operating Income	126.81B
Pretax Income	134.28B
Net Income	124.26B
EBITDA	154.63B
EBIT	126.81B
Earnings Per Share (EPS)	277.37

Full Income Statement

Balance Sheet

The company has 76.67 billion in cash and 18.45 billion in debt, giving a net cash position of 58.22 billion or 129.96 per share.

Cash & Cash Equivalents	76.67B
Total Debt	18.45B
Net Cash	58.22B
Net Cash Per Share	129.96
Equity (Book Value)	729.58B
Book Value Per Share	1,628.52
Working Capital	522.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 81.04 billion and capital expenditures -10.62 billion, giving a free cash flow of 70.42 billion.

Operating Cash Flow	81.04B
Capital Expenditures	-10.62B
Free Cash Flow	70.42B
FCF Per Share	157.19

Full Cash Flow Statement

Margins

Gross margin is 34.90%, with operating and profit margins of 13.57% and 13.36%.

Gross Margin	34.90%
Operating Margin	13.57%
Pretax Margin	14.37%
Profit Margin	13.36%
EBITDA Margin	16.54%
EBIT Margin	13.57%
FCF Margin	7.53%

Dividends & Yields

This stock pays an annual dividend of 320.00, which amounts to a dividend yield of 8.94%.

Dividend Per Share	320.00
Dividend Yield	8.94%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	114.93%
Buyback Yield	n/a
Shareholder Yield	8.94%
Earnings Yield	7.75%
FCF Yield	4.39%

Dividend Details

Stock Splits

The last stock split was on December 21, 2015. It was a forward split with a ratio of 20.

Last Split Date	Dec 21, 2015
Split Type	Forward
Split Ratio	20

Scores

PT Merck Tbk has an Altman Z-Score of 9.08.

Altman Z-Score	9.08
Piotroski F-Score	n/a